Both p21' and protein kinase C (PKC) are believed to function downstream of plasma membraneassociated tyrosine kinases in cellular signal transduction pathways. However, it has remained controversial whether they function in the same pathway and, if so, what their relative position and functional relationship in such a pathway are. We investigated the possibilities that p2l' and PKC function either upstream or downstream of each other in a common linear pathway or that they function independently in colinear signal pathways. Either decreased expression of endogenous normal ras in fibroblasts transfected with an inducible antisense ras construct or overexpression of a mutant ras gene reduced the capacity of the phorbol ester tetradecanoyl phorbol acetate to trigger expression of the tetradecanoyl phorbol acetate-responsive and ras-dependent reporter gene osteopontin (OPN). PKC depletion decreased basal OPN mRNA levels, and the overexpression of ras restored OPN expression to the level of non-PKC-depleted cells. We propose a model in which ras and PKC function in distinct and interdependent signaling pathways.Mammalian ras proteins (p2lras and Ras) play an important role in the control of cell proliferation and differentiation (38). However, their physiological role in signal transduction pathways that extend from ligand-receptor interactions at the cell surface to activation of gene expression in the nucleus is still incompletely understood. The observation that serum growth factor receptors as well as receptor and non-receptor-type oncogene products with tyrosine kinase (TK) activity require functional Ras to elicit mitogenic and oncogenic responses (2,8,27,29,46) suggests that p2lras acts downstream of TK. Protein kinase C (PKC), a ubiquitous phospholipid and Ca2+-dependent serine-threonine kinase (31), also functions downstream of TK along the phospholipase C-mediated pathway of phosphatidylinositol lipid (PI) turnover (14)(15)(16)30 parts (34,53). Scrape-loading experiments have demonstrated that a very early effect of p2lras is to activate PKC (28). Moreover, microinjection of antibodies against phospholipase C, an upstream effector of PKC activity in the PI pathway, inhibits DNA synthesis induced by Ras (47). These observations support the model of a linear signal transduction pathway in which p2lras activation precedes PKC function. However, the following experiments have prompted the opposite conclusion. Although transforming Ras alone does not stimulate a mitogenic response in cells in which PKC has been downregulated (20), the Ras-neutralizing monoclonal antibody (MAb) Y13-259 blocks TPA-induced mitogenesis in quiescent fibroblasts (55). Moreover, in T lymphocytes the activation of PKC enhances the activational state of p2lras, presumably by relaxing the effect of the regulatory GTPase-activating protein Ras.GAP (6). The latter data suggest that p2lras is positioned downstream of PKC in a linear signaling pathway.Most of the studies described above evaluated Ras and PKC function by analysis of DNA synth...